Netherlands
Strategy shaping and commercial execution driven Business Development & Commercial Executive enabling customers to be successful. Grounded with a strong foundation in strategic and business development, commercial excellence and growth-driven approach. Leading innovation and building customer value in fast moving markets across Life Sciences, Pharma, Biopharma, Biotech and Healthcare sectors. • Business Development & Go-to-Market Strategy • Sales Strategy, Commercial Results-Driven & Revenue Growth • Complex, Consultative & Value-Based Selling • Leading Market Implementation & Deal Execution • Cross-Functional Leadership & Strategic Stakeholder Management • Strong Business Acumen with Scientific & Technological Expertise • Sales Leadership, Coaching & High-Performance Team Building Awards: President's Club* 2022 | EMEA Sales Manager 2022 | President's Club 2019 Industry Focus: Life Sciences | Pharma | BioPharma | Biotech | Academic | Healthcare | Analytical Instrumentations Geographic Region: Europe | Global Markets * Thermo Fisher Scientific President's Club is an exclusive, annual sales recognition program for their top-performing global sales team members, honoring less than 4% of their elite sales professionals for outstanding achievements, highlighting dedication to driving success
Translating Scientific Innovations into Commercial Impact. VerNexum Advisory is a boutique strategic commercial advisory firm serving Life Sciences, Pharma, Biopharma, Biotech, and Healthcare organisations across EMEA. The firm is built on a single, deeply held conviction: great science deserves — and rarely receives — the commercial strategy it needs to reach its full potential. We partner to navigate the gap between scientific innovation and commercial success
Heading the Business Development for our Smart VHH nanobody discovery platform. As nanobodies are becoming increasingly important foundation for next-generation biologics. We have developed a synthetic discovery platform that combines a developability-focused nanobody framework with a ultra diverse smart synthetic library (containing 10Exp13, putative and functional nanobodies, and expanding). We support biotech and pharmaceutical companies discover developable nanobodies as a better starting points for successful drug development.
A key member of the EMEA commercial team providing strategic guidance and leadership to the EMEA sales teams aiming to develop the Life Sciences Mass Spectrometry in CRO, Biopharma, Translational Proteomics, Clinical, Environmental market share in EMEA
Commercial Leadership role with growing booking (to 50+ MUSD) and responsibilities over time to the Full CMD Divisional Portfolio covering the analytical instrument, HPLC, IC, SP, TEA, DIA, GC and LC-MS including consumables and services. The team expanding to 12 direct and indirect reports, Sales Manager, Key Account Managers and Digital AM. Markets: Academica, Pharma, Biopharma, CRO, Biotech, Healthcare, Industry, Food & Environmental